MBX Biosciences Statistics
Total Valuation
MBX has a market cap or net worth of $749.80 million. The enterprise value is $847.14 million.
Important Dates
The next estimated earnings date is Saturday, November 16, 2024, before market open.
Earnings Date | Nov 16, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MBX has 33.38 million shares outstanding.
Shares Outstanding | 33.38M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +4.50% |
Owned by Insiders (%) | 2.99% |
Owned by Institutions (%) | 7.65% |
Float | 13.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.17, with a Debt / Equity ratio of 0.00.
Current Ratio | 7.17 |
Quick Ratio | 6.76 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.75M |
Employee Count | 27 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 48.31 |
Average Volume (20 Days) | 112,735 |
Short Selling Information
The latest short interest is 311,843, so 0.93% of the outstanding shares have been sold short.
Short Interest | 311,843 |
Short Previous Month | 363,738 |
Short % of Shares Out | 0.93% |
Short % of Float | 2.26% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -50.91M |
Pretax Income | -47.20M |
Net Income | -47.20M |
EBITDA | -50.72M |
EBIT | -50.91M |
Earnings Per Share (EPS) | -$3.35 |
Full Income Statement Balance Sheet
The company has $55.26 million in cash and $249,000 in debt, giving a net cash position of $55.01 million or $1.65 per share.
Cash & Cash Equivalents | 55.26M |
Total Debt | 249,000 |
Net Cash | 55.01M |
Net Cash Per Share | $1.65 |
Equity (Book Value) | 54.47M |
Book Value Per Share | -6.18 |
Working Capital | 50.60M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$42.85 million and capital expenditures -$802,000, giving a free cash flow of -$43.65 million.
Operating Cash Flow | -42.85M |
Capital Expenditures | -802,000 |
Free Cash Flow | -43.65M |
FCF Per Share | -$1.31 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |